Rebecca Klisovic

5PUBLICATIONS
18CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 07, 2026
A phase II study of low dose melphalan with thiotepa and fludarabine as preparative regimen for alternative donor transplantation.

|Apr 30, 2025
Pegylated Interferons: Still a Major Player for the Treatment of Myeloproliferative Neoplasms.

Michael Daunov, Rebecca B Klisovic

|Sep 09, 2024
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis.

Chenyu Lin, Anand A Patel, Dezheng Huo

|Feb 14, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.

Anjali S Advani, Anna Moseley, Kristen M O'Dwyer

Pageof 1

Frequent Collaborators

3 joint publications

Koen van Besien

2 joint publications

Michael Daunov

2 joint publications

Benjamin Tomlinson

2 joint publications

Nikki Agarwal